To Treat Frontotemporal Dementia, Treat the Brain’s Immune Cells
Though FTD is not as well known as Alzheimer’s disease, it’s the second most common cause of dementia in people under 65, and there’s currently no treatment.
University of California San Francisco
Give to UCSFThough FTD is not as well known as Alzheimer’s disease, it’s the second most common cause of dementia in people under 65, and there’s currently no treatment.
New UCSF research sheds light on how immune system B cells that infiltrate the central nervous system may drive multiple sclerosis.
UCSF researchers are taking a closer look at COVID-19’s dizzying array of symptoms to get at the disease’s root causes.
As the United States’ testing regime floundered early in the pandemic, scientists at UCSF and the Chan Zuckerberg Biohub created from scratch a diagnostic lab that became a model for the nation.
A look at past outbreaks offers guidance on bringing the current one to an end – and on thwarting the next one.
How I learned to use social media to advance the public’s understanding of COVID-19.
Joel Ernst, MD, addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.
Clinical trial leader Annie Luetkemeyer, MD, tests promising therapies for COVID-19 – and soon a vaccine.
The finding could offer additional insights into other immune conditions, including a type of childhood leukemia and the severe inflammation response in some children with COVID-19.
Depending on a cancer’s tissue of origin, tumors cause widespread and variable disruption of the immune system throughout the body, not just at the primary tumor site.
Cancer specialists from UCSF will present new research findings at the annual scientific program of the American Society of Clinical Oncology, the world’s largest clinical cancer research meeting.